Kamari Pharma Announces Abstracts Accepted for Presentation at the 81st Annual Meeting of the Society for Investigative Dermatology Late breaking poster presentation includes Phase 1b clinical trial results demonstrating the safety and preliminary efficacy of KM-001, a topical TRPV3 inhibitor, for the treatment of palmoplantar...

Annual federal report to Congress notes progress, highlights gaps in enforcement of disability laws WASHINGTON, Oct. 31, 2019 (GLOBE NEWSWIRE) -- The National Council on Disability (NCD)—an independent federal agency—today released its annual progress report on national disability policy, titled,...